ID   SHPRH_HUMAN             Reviewed;        1683 AA.
AC   Q149N8; Q149N9; Q5VV79; Q68DS5; Q7Z5J5; Q8IVE8; Q8IWQ9; Q8N1S8;
AC   Q8NBR7;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   10-MAY-2017, entry version 112.
DE   RecName: Full=E3 ubiquitin-protein ligase SHPRH;
DE            EC=2.3.2.27;
DE            EC=3.6.4.-;
DE   AltName: Full=RING-type E3 ubiquitin transferase SHPRH {ECO:0000305};
DE   AltName: Full=SNF2, histone-linker, PHD and RING finger domain-containing helicase;
GN   Name=SHPRH; Synonyms=KIAA2023;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANTS ARG-438; PHE-460 AND TYR-1028.
RX   PubMed=12837266; DOI=10.1016/S0888-7543(03)00121-6;
RA   Sood R., Makalowska I., Galdzicki M., Hu P., Eddings E., Robbins C.M.,
RA   Moses T., Namkoong J., Chen S., Trent J.M.;
RT   "Cloning and characterization of a novel gene, SHPRH, encoding a
RT   conserved putative protein with SNF2/helicase and PHD-finger domains
RT   from the 6q24 region.";
RL   Genomics 82:153-161(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RA   Chen S., Yu L., Guo J.H.;
RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Salivary gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-584 AND 1532-1683 (ISOFORM
RP   1).
RC   TISSUE=Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 23-1683 (ISOFORM 4).
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, HOMODIMERIZATION, INTERACTION WITH PCNA; UBE2N AND RAD18,
RP   AND MUTAGENESIS OF CYS-1432.
RX   PubMed=17130289; DOI=10.1083/jcb.200606145;
RA   Motegi A., Sood R., Moinova H., Markowitz S.D., Liu P.P., Myung K.;
RT   "Human SHPRH suppresses genomic instability through proliferating cell
RT   nuclear antigen polyubiquitination.";
RL   J. Cell Biol. 175:703-708(2006).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH UBE2N AND RAD18.
RX   PubMed=17108083; DOI=10.1073/pnas.0608595103;
RA   Unk I., Hajdu I., Fatyol K., Szakal B., Blastyak A., Bermudez V.,
RA   Hurwitz J., Prakash L., Prakash S., Haracska L.;
RT   "Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent
RT   polyubiquitylation of proliferating cell nuclear antigen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:18107-18112(2006).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH HLTF.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X.,
RA   Moinova H., Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and
RT   SHPRH prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   VARIANT ASP-1222.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase involved in DNA repair. Upon
CC       genotoxic stress, accepts ubiquitin from the UBE2N-UBE2V2 E2
CC       complex and transfers it to 'Lys-164' of PCNA which had been
CC       monoubiquitinated by UBE2A/B-RAD18, promoting the formation of
CC       non-canonical poly-ubiquitin chains linked through 'Lys-63'.
CC       {ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:17130289,
CC       ECO:0000269|PubMed:18719106}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homodimer. Interacts with HLTF, PCNA, UBE2N and RAD18.
CC       {ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:17130289,
CC       ECO:0000269|PubMed:18719106}.
CC   -!- INTERACTION:
CC       Q96GS4:BORCS6; NbExp=3; IntAct=EBI-714105, EBI-10193358;
CC       Q8WWZ3:EDARADD; NbExp=3; IntAct=EBI-714105, EBI-2949647;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q149N8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q149N8-2; Sequence=VSP_024753, VSP_024757, VSP_024758;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=Q149N8-4; Sequence=VSP_024756, VSP_024759, VSP_024762,
CC                                  VSP_024763;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q149N8-5; Sequence=VSP_024760, VSP_024761;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Broadly expressed.
CC       {ECO:0000269|PubMed:12837266}.
CC   -!- DOMAIN: The RING finger mediates E3 ubiquitin ligase activity.
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI13090.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=AAI17686.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=BAC04459.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC23119.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC       Sequence=CAH18145.1; Type=Frameshift; Positions=762, 997; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY161136; AAO26201.1; -; mRNA.
DR   EMBL; AY163808; AAO06907.1; -; mRNA.
DR   EMBL; CR749290; CAH18145.1; ALT_FRAME; mRNA.
DR   EMBL; AL356599; CAI41120.1; -; Genomic_DNA.
DR   EMBL; AL451145; CAI41120.1; JOINED; Genomic_DNA.
DR   EMBL; AL451145; CAH70765.1; -; Genomic_DNA.
DR   EMBL; AL356599; CAH70765.1; JOINED; Genomic_DNA.
DR   EMBL; BC113089; AAI13090.1; ALT_SEQ; mRNA.
DR   EMBL; BC117685; AAI17686.1; ALT_SEQ; mRNA.
DR   EMBL; BC117686; AAI17687.1; -; mRNA.
DR   EMBL; AK075318; BAC11544.1; -; mRNA.
DR   EMBL; AK094944; BAC04459.1; ALT_INIT; mRNA.
DR   EMBL; AB095943; BAC23119.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS43513.2; -. [Q149N8-1]
DR   CCDS; CCDS47496.1; -. [Q149N8-4]
DR   RefSeq; NP_001036148.2; NM_001042683.2. [Q149N8-1]
DR   RefSeq; NP_775105.1; NM_173082.3. [Q149N8-4]
DR   RefSeq; XP_006715504.1; XM_006715441.3. [Q149N8-1]
DR   UniGene; Hs.723297; -.
DR   PDB; 2M85; NMR; -; A=652-716.
DR   PDB; 4QN1; X-ray; 2.48 A; A=1000-1418.
DR   PDBsum; 2M85; -.
DR   PDBsum; 4QN1; -.
DR   ProteinModelPortal; Q149N8; -.
DR   SMR; Q149N8; -.
DR   BioGrid; 129208; 17.
DR   DIP; DIP-46277N; -.
DR   IntAct; Q149N8; 7.
DR   MINT; MINT-1370426; -.
DR   STRING; 9606.ENSP00000275233; -.
DR   iPTMnet; Q149N8; -.
DR   PhosphoSitePlus; Q149N8; -.
DR   BioMuta; SHPRH; -.
DR   DMDM; 146325723; -.
DR   EPD; Q149N8; -.
DR   MaxQB; Q149N8; -.
DR   PaxDb; Q149N8; -.
DR   PeptideAtlas; Q149N8; -.
DR   PRIDE; Q149N8; -.
DR   Ensembl; ENST00000275233; ENSP00000275233; ENSG00000146414. [Q149N8-1]
DR   Ensembl; ENST00000367505; ENSP00000356475; ENSG00000146414. [Q149N8-1]
DR   Ensembl; ENST00000438092; ENSP00000412797; ENSG00000146414. [Q149N8-4]
DR   Ensembl; ENST00000519632; ENSP00000430528; ENSG00000146414. [Q149N8-2]
DR   GeneID; 257218; -.
DR   KEGG; hsa:257218; -.
DR   UCSC; uc003qle.4; human. [Q149N8-1]
DR   CTD; 257218; -.
DR   DisGeNET; 257218; -.
DR   GeneCards; SHPRH; -.
DR   HGNC; HGNC:19336; SHPRH.
DR   HPA; HPA034854; -.
DR   HPA; HPA034950; -.
DR   MIM; 608048; gene.
DR   neXtProt; NX_Q149N8; -.
DR   OpenTargets; ENSG00000146414; -.
DR   PharmGKB; PA134880315; -.
DR   eggNOG; KOG0298; Eukaryota.
DR   eggNOG; COG0553; LUCA.
DR   GeneTree; ENSGT00730000111123; -.
DR   HOVERGEN; HBG059171; -.
DR   InParanoid; Q149N8; -.
DR   KO; K15710; -.
DR   PhylomeDB; Q149N8; -.
DR   TreeFam; TF324273; -.
DR   SIGNOR; Q149N8; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; SHPRH; human.
DR   GeneWiki; SHPRH; -.
DR   GenomeRNAi; 257218; -.
DR   PRO; PR:Q149N8; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000146414; -.
DR   ExpressionAtlas; Q149N8; baseline and differential.
DR   Genevisible; Q149N8; HS.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IDA:MGI.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:FlyBase.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:FlyBase.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 1.25.40.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000330; SNF2_N.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF00538; Linker_histone; 1.
DR   Pfam; PF00176; SNF2_N; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00526; H15; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SMART; SM00249; PHD; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF52540; SSF52540; 6.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51504; H15; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   DNA damage; DNA repair; Helicase; Hydrolase; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   1683       E3 ubiquitin-protein ligase SHPRH.
FT                                /FTId=PRO_0000284918.
FT   DOMAIN      307    389       Helicase ATP-binding; first part.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN      438    512       H15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00837}.
FT   DOMAIN      710    868       Helicase ATP-binding; second part.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN     1514   1672       Helicase C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00542}.
FT   NP_BIND     373    380       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00541}.
FT   ZN_FING     658    709       PHD-type.
FT   ZN_FING    1432   1479       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   MOTIF       819    822       DEAQ box.
FT   MOD_RES     266    266       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     635    635       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7TPQ3}.
FT   VAR_SEQ      46    156       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_024753.
FT   VAR_SEQ     442    471       TRVMILTAVKEMNGKKGVSILSIYKYVSSI -> YPFTFSY
FT                                TCDDTDSCERNEWKKRSVHPFHL (in isoform 4).
FT                                {ECO:0000303|Ref.7}.
FT                                /FTId=VSP_024760.
FT   VAR_SEQ     472   1683       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.7}.
FT                                /FTId=VSP_024761.
FT   VAR_SEQ     996    996       K -> KSFEQSTFSF (in isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_024756.
FT   VAR_SEQ    1039   1040       EY -> RR (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_024757.
FT   VAR_SEQ    1041   1683       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_024758.
FT   VAR_SEQ    1183   1187       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_024759.
FT   VAR_SEQ    1653   1655       HTN -> IYI (in isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_024762.
FT   VAR_SEQ    1656   1683       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_024763.
FT   VARIANT     438    438       Q -> R (in an ovarian cancer cell line).
FT                                {ECO:0000269|PubMed:12837266}.
FT                                /FTId=VAR_031857.
FT   VARIANT     460    460       S -> F (in a melanoma cell line).
FT                                {ECO:0000269|PubMed:12837266}.
FT                                /FTId=VAR_031858.
FT   VARIANT    1028   1028       N -> Y (in a melanoma cell line).
FT                                {ECO:0000269|PubMed:12837266}.
FT                                /FTId=VAR_031859.
FT   VARIANT    1222   1222       V -> D (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064750.
FT   MUTAGEN    1432   1432       C->A: Abolishes E3 activity.
FT                                {ECO:0000269|PubMed:17130289}.
FT   CONFLICT    185    185       M -> V (in Ref. 3; CAH18145).
FT                                {ECO:0000305}.
FT   CONFLICT    379    379       K -> E (in Ref. 6; BAC11544).
FT                                {ECO:0000305}.
FT   CONFLICT    425    425       E -> G (in Ref. 6; BAC11544).
FT                                {ECO:0000305}.
FT   CONFLICT    560    560       D -> G (in Ref. 3; CAH18145).
FT                                {ECO:0000305}.
FT   CONFLICT   1398   1398       V -> F (in Ref. 5; AAI17687).
FT                                {ECO:0000305}.
FT   TURN        669    671       {ECO:0000244|PDB:2M85}.
FT   STRAND      674    677       {ECO:0000244|PDB:2M85}.
FT   TURN        678    681       {ECO:0000244|PDB:2M85}.
FT   STRAND      682    685       {ECO:0000244|PDB:2M85}.
FT   HELIX       686    688       {ECO:0000244|PDB:2M85}.
FT   TURN        694    698       {ECO:0000244|PDB:2M85}.
FT   HELIX       704    710       {ECO:0000244|PDB:2M85}.
FT   HELIX      1000   1037       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1040   1056       {ECO:0000244|PDB:4QN1}.
FT   TURN       1057   1060       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1065   1080       {ECO:0000244|PDB:4QN1}.
FT   TURN       1081   1084       {ECO:0000244|PDB:4QN1}.
FT   TURN       1090   1094       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1095   1119       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1122   1133       {ECO:0000244|PDB:4QN1}.
FT   STRAND     1137   1139       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1141   1151       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1155   1166       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1180   1182       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1186   1212       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1220   1230       {ECO:0000244|PDB:4QN1}.
FT   STRAND     1234   1236       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1242   1257       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1296   1310       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1315   1359       {ECO:0000244|PDB:4QN1}.
FT   HELIX      1385   1414       {ECO:0000244|PDB:4QN1}.
SQ   SEQUENCE   1683 AA;  193079 MW;  3EAA1433EF89B232 CRC64;
     MSSRRKRAPP VRVDEEKRQQ LHWNMHEDRR NEPIIISDDD EQPCPGSDTS SAHYIILSDS
     LKEEVAHRDK KRCSKVVSFS KPIEKEETVG IFSPLSVKLN IVISPYHFDN SWKAFLGELT
     LQLLPAQSLI ENFSERSITL MSSESSNQFL IYVHSKGEDV EKQKKEPMSI CDKGILVESS
     FSGEMLEDLG WLQKKRRIKL YQKPEGNHII KVGIYLLEAG LAKLDFLSDA NSRMKKFNQL
     MKKVMEKLHN SIIPDVLEED EDDPESEPEG QDIDELYHFV KQTHQQETQS IQVDVQHPAL
     IPVLRPYQRE AVNWMLQQEC FRSSPATESA LHFLWREIVT SEGLKLYYNP YTGCIIREYP
     NSGPQLLGGI LADEMGLGKT VEVLALILTH TRQDVKQDAL TLPEGKVVNY FIPSHYFGGK
     LKKTEIQNIE FEPKEKVQCP PTRVMILTAV KEMNGKKGVS ILSIYKYVSS IYRYDVQRNR
     SLLKRMLKCL IFEGLVKQIK GHGFSGTFTL GKNYKEEDIC DKTKKQAVGS PRKIQKETRK
     SGNKDTDSEY LPSDTSDDDD DPYYYYYKSR RNRSKLRKKL VPSTKKGKSQ PFINPDSQGH
     CPATSDSGIT DVAMSKSTCI SEFNQEHETE DCAESLNHAD SDVPPSNTMS PFNTSDYRFE
     CICGELDQID RKPRVQCLKC HLWQHAKCVN YDEKNLKIKP FYCPHCLVAM EPVSTRATLI
     ISPSSICHQW VDEINRHVRS SSLRVLVYQG VKKDGFLQPH FLAEQDIVII TYDVLRSELN
     YVDIPHSNSE DGRRLRNQKR YMAIPSPLVA VEWWRICLDE AQMVECPTVK AAEMAQRLSG
     INRWCISGTP VQRGLEDLFG LVVFLGIEPY CVKHWWVRLL YRPYCKKNPQ HLYSFIAKIL
     WRSAKKDVID QIQIPPQTEE IHWLHFSPVE RHFYHRQHEV CCQDVVVKLR KISDWALKLS
     SLDRRTVTSI LYPLLRLRQA CCHPQAVRGE FLPLQKSTMT MEELLTSLQK KCGTECEEAH
     RQLVCALNGL AGIHIIKGEY ALAAELYREV LRSSEEHKGK LKTDSLQRLH ATHNLMELLI
     ARHPGIPPTL RDGRLEEEAK QLREHYMSKC NTEVAEAQQA LYPVQQTIHE LQRKIHSNSP
     WWLNVIHRAI EFTIDEELVQ RVRNEITSNY KQQTGKLSMS EKFRDCRGLQ FLLTTQMEEL
     NKCQKLVREA VKNLEGPPSR NVIESATVCH LRPARLPLNC CVFCKADELF TEYESKLFSN
     TVKGQTAIFE EMIEDEEGLV DDRAPTTTRG LWAISETERS MKAILSFAKS HRFDVEFVDE
     GSTSMDLFEA WKKEYKLLHE YWMALRNRVS AVDELAMATE RLRVRDPREP KPNPPVLHII
     EPHEVEQNRI KLLNDKAVAT SQLQKKLGQL LYLTNLEKSQ DKTSGGVNPE PCPICARQLG
     KQWAVLTCGH CFCNECISII IEQYSVGSHR SSIKCAICRQ TTSHKEISYV FTSEKANQEE
     DIPVKGSHST KVEAVVRTLM KIQLRDPGAK ALVFSTWQDV LDIISKALTD NNMEFAQISR
     VKTFQENLSA FKRDPQINIL LLPLHTGSNG LTIIEATHVL LVEPILNPAH ELQAIGRVHR
     IGQTKPTIVH RFLIKATIEE RMQAMLKTAE RSHTNSSAKH SEASVLTVAD LADLFTKETE
     ELE
//
